News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DFine Announces First U.S. Patient Treated with the STAR Ablation System


3/14/2012 10:25:52 AM

SAN JOSE, Calif.--(BUSINESS WIRE)--DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced the first U.S. patient was successfully treated using the Spinal Tumor Ablation with Radiofrequency (STAR™) System. The FDA-commercially cleared, percutaneous Targeted RadioFrequency Ablation (t-RFA™) device delivers energy directly into a metastatic vertebral body tumor to heat and destroy tumor cells and provide palliative pain relief.

Read at BioSpace.com


comments powered by Disqus
DFine
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES